Tak Yun
1PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Aug 29, 2023
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.Glenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar
Pageof 1
Frequent Collaborators
1 joint publications
Glenn J Hanna
1 joint publications
Myung-Ju Ahn
1 joint publications
Jameel Muzaffar
1 joint publications
Bhumsuk Keam
1 joint publications
Daniel W Bowles
1 joint publications
Deborah J Wong
1 joint publications
Alan L Ho
1 joint publications
Sung-Bae Kim
1 joint publications
Francis Worden
1 joint publications
Xianzhang Meng
